Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction

The Original Article was published on 06 October 2021

Correction to: Nature Published online 30 June 2021

In this version of this Article originally published, there were errors in Fig. 2 and in the references list. Specifically, in the Fig. 2c colour key, the middle cyan key now reading “JNJ-A07, 10 mg per kg, b.i.d” was missing the number of units, “10,” in the originally published version. Further, refs. 27 and 28 were swapped in the references list; their correct order appears below. The original Article has been corrected online.


  1. 27.

    Low, J. G., Ooi, E. E. & Vasudevan, S. G. Current status of dengue therapeutic research and development. J. Infect. Dis. 215, S96–S102 (2017).

  2. 28.

    Unlocking the Potential of Preventive Therapies for Malaria. World Health Organization, (7 April 2017).

Download references

Author information



Corresponding authors

Correspondence to Marnix Van Loock or Johan Neyts.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kaptein, S.J.F., Goethals, O., Kiemel, D. et al. Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction. Nature 599, E2 (2021).

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing